Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9TXW

Catalytic domain of human tankyrase 2 in complex with benzamide adenine dinucleotide (BAD)

Summary for 9TXW
Entry DOI10.2210/pdb9txw/pdb
Related6BHV 7OJO
DescriptorPoly [ADP-ribose] polymerase tankyrase-2, ZINC ION, SULFATE ION, ... (6 entities in total)
Functional Keywordsadp-ribosylation, parp, tnks2, transferase
Biological sourceHomo sapiens (human)
More
Total number of polymer chains4
Total formula weight51514.08
Authors
Paakkonen, J.,Lehtio, L. (deposition date: 2026-01-16, release date: 2026-08-05)
Primary citationPaakkonen, J.,Sowa, S.T.,Bosetti, C.,Lehtio, L.
Replacement soaking for human tankyrase 2 enables studies on substrate analogues and inhibitors.
Acta Crystallogr D Struct Biol, 2026
Cited by
PubMed Abstract: Crystallography has facilitated the development of inhibitors in modern drug discovery. Complex structures are traditionally obtained by co-crystallization or soaking methods, but they are not always successful; co-crystallization may lead to selective crystallization of the apoprotein, and compounds cannot necessarily be soaked into preformed crystals. Successful endeavours in this field include human tankyrases TNKS1 and TNKS2, which are promising drug targets controlling a wide range of signalling events. In the case of TNKS2, apo crystals have a closed conformation in the donor loop, delineating the NAD-binding active site, and compound soaking requires a large conformational change, which often damages the crystals and deteriorates the diffraction quality. This work describes a crystal form of TNKS2 that can be used efficiently in replacement soaking (also known as cross-soaking) when TNKS2 is co-crystallized with a low-affinity inhibitor. Replacement soaking is demonstrated with recently described nanomolar inhibitors as well as a nonhydrolysable analogue of NAD, which all occupy the substrate-binding site. The obtained complex structures offer new insight into the binding modes of the inhibitors and the substrate NAD, and comparison to previously published complex structures of closely related PARP proteins with NAD analogues reveals key characteristics of the NAD-binding site of TNKS2. In cases where traditional methods fail to yield complex structures, the replacement soaking method provides an alternative method, which was demonstrated here to be necessary for elucidating the complex structures.
PubMed: 42522928
DOI: 10.1107/S2059798326006868
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

257629

PDB entries from 2026-08-05

PDB statisticsPDBj update infoContact PDBjnumon